Quantity and Reporting Quality of Kidney Research
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Background: In 2004, researchers reported that the number of nephrology clinical trials was low and that the reporting quality of such trials was suboptimal. Furthermore, the number or quality of preclinical kidney-related studies has not been systematically evaluated. Methods: We performed a systematic review of randomized clinical trials published in 1966–2017 (listed in the Cochrane Library) and preclinical studies published in 1945–2017 (listed in PubMed). For reporting quality analysis, we evaluated the final main paper of 118 clinical trial reports and 135 preclinical studies published in leading journals in 1996, 2006, and 2016 on the basis of criteria from the widely used CONSORT and ARRIVE guidelines. Results: The annual number of reports of clinical kidney-related trials more than doubled between 2004 and 2014 along with reports in other medical disciplines. Hypertension remains the dominant focus of study, but ongoing trials also center on CKD, ESRD, and AKI. The reporting quality analysis revealed improvements, but deficits in reporting of clinical trial design, mode of randomization, and intention-to-treat analysis remain. Annual numbers of kidney-related preclinical studies remained low between 1945 and 2017 compared with other disciplines. Reporting quality analysis of preclinical studies revealed substantial reporting deficits across all leading journals, with little improvement over the last 20 years, especially for group size calculations, defining primary versus secondary outcomes, and blinded analysis. Conclusions: Nephrology studies keep increasing in number but still lag behind other medical disciplines, and the quality of data reporting in kidney research can be further improved.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research
Kilkenny, C., Browne, W. J., Cuthill, I. C., Emerson, M., & Altman, D. G. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000412 · Cited by 7,300
Improving bioscience research reporting: The ARRIVE guidelines for reporting animal research
Kilkenny, C., Browne, W. J., Cuthill, I. C., Emerson, M., & Altman, D. G. (2010) · Journal of Pharmacology and Pharmacotherapeutics · doi:10.4103/0976-500x.72351 · Cited by 6,277
Raise standards for preclinical cancer research
Begley, C. G., & Ellis, L. M. (2012) · Nature · doi:10.1038/483531a · Cited by 2,979
Can Animal Models of Disease Reliably Inform Human Studies?
van der Worp, H. B., Howells, D. W., Sena, E. S., Porritt, M. J., Rewell, S., O'Collins, V., & Macleod, M. R. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000245 · Cited by 1,354
Kilkenny, C., Parsons, N., Kadyszewski, E., Festing, M. F. W., Cuthill, I. C., Fry, D., Hutton, J., & Altman, D. G. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007824 · Cited by 860
The need for randomization in animal trials: an overview of systematic reviews
Hirst, J. A., Howick, J., Aronson, J. K., Roberts, N., Perera, R., Koshiaris, C., & Heneghan, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098856 · Cited by 294
Vasilevsky, N. A., Brush, M. H., Paddock, H., Ponting, L., Tripathy, S. J., LaRocca, G. M., & Haendel, M. A. (2013) · PeerJ · doi:10.7717/peerj.148 · Cited by 271
Do you know the sex of your cells?
Shah, K., McCormack, C. E., & Bradbury, N. A. (2014) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00281.2013 · Cited by 219
Research works printed but not linked: 6
- Strippoli, 2004, The number, quality, and coverage of randomized controlled trials in nephrology, J Am Soc Nephrol, 15, 411, 10.1097/01.ASN.0000100125.21491.46 · DOI · Paper page
- Deo, 2011, Loss to analysis in randomized controlled trials in CKD, Am J Kidney Dis, 58, 349, 10.1053/j.ajkd.2011.04.023 · DOI
- Braybrook, 2017, Reproducibility: Developing standard measures for biology, Nature, 551, 168, 10.1038/d41586-017-05780-5 · doi:10.1038/d41586-017-05780-5
- Hsieh, 2018, Enhancing scientific foundations to ensure reproducibility: A new paradigm, Am J Pathol, 188, 6, 10.1016/j.ajpath.2017.08.028 · DOI
- Anders, 2016, Hurdles to the introduction of new therapies for immune-mediated kidney diseases, Nat Rev Nephrol, 12, 205, 10.1038/nrneph.2015.206 · DOI
- Miller, 2017, Considering sex as a biological variable in preclinical research, FASEB J, 31, 29, 10.1096/fj.201600781r · DOI · Paper page
Cited by
Dapagliflozin in Patients with Chronic Kidney Disease
Heerspink, H. J. L., Stefánsson, B. V., Correa-Rotter, R., Chertow, G. M., Greene, T., Hou, F.-F., Mann, J. F. E., McMurray, J. J. V., Lindberg, M., Rossing, P., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2024816 · Cited by 5,618
International consensus definitions of clinical trial outcomes for kidney failure: 2020
Levin, A., Agarwal, R., Herrington, W. G., Heerspink, H. L., Mann, J. F. E., Shahinfar, S., Tuttle, K. R., Donner, J.-A., Jha, V., Nangaku, M., et al. (2020) · Kidney International · doi:10.1016/j.kint.2020.07.013 · Cited by 125
Predictors of Survival in Chronic Hemodialysis Patients: A 10-Year Longitudinal Follow-Up Analysis
Moromizato, T., Kohagura, K., Tokuyama, K., Shiohira, Y., Toma, S., Uehara, H., Arima, H., Ueda, S., & Iseki, K. (2021) · American Journal of Nephrology · doi:10.1159/000513951 · Cited by 15
Metadata
- Authors
- Chatzimanouil, M. K. T., Wilkens, L., & Anders, H.-J.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2018-12-13
- Volume
- 30
- Issue
- 1
- Pages
- 13-22
- ISSN
- 1046-6673 (ISSN-L)
- 1533-3450
- OpenAlex
- W2904077247
- Cited by
- 60
- References
- 8
- FWCI
- 5.73
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Quantity and Reporting Quality of Kidney Research. https://app.cochat.ai/papers/10.1681/asn.2018050515
- The paper
- Chatzimanouil, M. K. T., Wilkens, L., & Anders, H.-J. (2019). Quantity and Reporting Quality of Kidney Research. Journal of the American Society of Nephrology. https://doi.org/10.1681/asn.2018050515
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.